RedHill Biopharma Ltd.
Price Action
Technical Summary
WEAKENINGRedHill Biopharma Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 35), showing significant lag compared to the market leaders. Investors should exercise caution due to high volatility (97% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.94 | +6.93% | ABOVE |
| 50 SMA | $0.89 | +13.01% | ABOVE |
| 100 SMA | $1.03 | -1.49% | BELOW |
| 150 SMA | $1.13 | -10.97% | BELOW |
| 200 SMA | $1.23 | -17.77% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is RDHL in an uptrend right now?
RDHL has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is RDHL overbought or oversold?
RDHL's RSI (14) is 60. The stock is in neutral territory, neither overbought nor oversold.
Is RDHL outperforming the market?
RDHL has a Relative Strength (RS) Rating of 35 out of 99. RDHL is currently lagging the broader market.
Where is RDHL in its 52-week range?
RDHL is trading at $1.01, which is 31% of its 52-week high ($3.31) and 12% above its 52-week low ($0.71).
How volatile is RDHL?
RDHL has a Beta of 1.30 and 52-week volatility of 97%. It's more volatile than the S&P 500 - expect bigger swings.